首页 | 本学科首页   官方微博 | 高级检索  
     


Platinum Chemotherapy Hypersensitivity: Prevalence and Management
Affiliation:1. Department of Medicine, Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine, UCSF Medical Center, 400 Parnassus Avenue, Fifth Floor, San Francisco, CA 94143, USA;2. Department of Medicine, Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA;1. Division of Allergy and Immunology, UT Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390, USA;2. Division of Allergy and Immunology, The Corvallis Clinic, 3680 NW Samaritan Dr, Corvallis, OR 97330, USA;3. Oregon State University/Oregon Health & Science University College of Pharmacy, 1601 SW Jefferson Way, Corvallis, OR 97331, USA;1. Division of Rheumatology, Allergy, and Immunology, Brigham and Women''s Hospital, Harvard Medical School, Boston, Mass;2. Department of Epidemiology and Biostatistics, SUNY Downstate School of Public Health, Brooklyn, NY;3. Dana Farber Cancer Institute, Harvard Medical School, Boston, Mass
Abstract:
Keywords:Platinum agent  Carboplatin  Cisplatin  Oxaliplatin  Chemotherapy allergy  Chemotherapy hypersensitivity  Chemotherapy desensitization
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号